ResearcherUniversity of PalermoNo recent work listed
Antonio Dello Russo
Matched on ORCID iD 0000-0002-4370-2008; OpenAlex author ID A5100635707. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 43
2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers
Papers 10
- Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società I… Co-author DOI 10.1016/j.esmoop.2021.100155↗
- Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: l… Co-author DOI 10.1016/j.esmoop.2021.100235↗
- Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma. Co-author DOI 10.1080/2162402x.2018.1561120↗
- Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safet… Co-author DOI 10.18632/oncotarget.25870↗
- Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer. Co-author DOI 10.1186/s13045-016-0371-1↗
- Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin. Co-author DOI 10.3233/cbm-160645↗
- MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets? First author DOI 10.18632/oncotarget.4492↗
- Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susc… Last author DOI 10.1517/14728222.2014.920324↗
- Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations. Last author DOI 10.1159/000354737↗
- Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. Co-author DOI 10.1007/s10689-011-9483-5↗
Closest collaborators
The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daniele Fanale · 4 shared papers, 2013–2021 · strength 0.26
- Paper Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients … DOI 10.1016/j.esmoop.2021.100235↗
- Paper Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcin… DOI 10.1080/2162402x.2018.1561120↗
- Paper Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target in… DOI 10.1517/14728222.2014.920324↗
- Viviana Bazan · 3 shared papers, 2013–2021 · strength 0.17
- Paper Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients … DOI 10.1016/j.esmoop.2021.100235↗
- Paper Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target in… DOI 10.1517/14728222.2014.920324↗
- Paper Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific var… DOI 10.1159/000354737↗
- Juan Iovanna · 3 shared papers, 2013–2019 · strength 0.16
- Paper Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcin… DOI 10.1080/2162402x.2018.1561120↗
- Paper Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target in… DOI 10.1517/14728222.2014.920324↗
- Paper Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific var… DOI 10.1159/000354737↗
- Nicola Silvestris · 2 shared papers, 2015–2021 · strength 0.14
- Marco Gallo · 1 shared paper, 2021 · strength 0.10
- Marco Bono · 1 shared paper, 2021 · strength 0.10
- Antonella Argentiero · 1 shared paper, 2021 · strength 0.10
- Pietro Ferrari · 1 shared paper, 2021 · strength 0.10
- Romano Danesi · 1 shared paper, 2021 · strength 0.10
- Francesco Giorgino · 1 shared paper, 2021 · strength 0.10
- Benjamin Bian · 1 shared paper, 2019 · strength 0.09
- Daniel Olive · 1 shared paper, 2019 · strength 0.09
- Nelson Dusetti · 1 shared paper, 2019 · strength 0.09
- Daniele Santini · 2 shared papers, 2014–2015 · strength 0.08
- Enrico Ricevuto · 1 shared paper, 2018 · strength 0.08
- Gemma Bruera · 1 shared paper, 2018 · strength 0.08
- Giuseppe Cicero · 2 shared papers, 2013–2014 · strength 0.07
- Paper Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target in… DOI 10.1517/14728222.2014.920324↗
- Paper Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific var… DOI 10.1159/000354737↗
- Mina Maftouh · 1 shared paper, 2017 · strength 0.06
- Amir Avan · 1 shared paper, 2017 · strength 0.06
- Daniela Massihnia · 1 shared paper, 2017 · strength 0.06
- Niccola Funel · 1 shared paper, 2017 · strength 0.06
- Ugo Boggi · 1 shared paper, 2017 · strength 0.06
- Godefridus J. Peters · 1 shared paper, 2017 · strength 0.06
- Elisa Giovannetti · 1 shared paper, 2017 · strength 0.06
- Mario Roselli · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.